Duvelisib Had Consistent Response Rates in R/R Peripheral T-Cell Lymphoma
Response appears to be consistent across histological subtypes.
Lymphoma
Partial Response or Better Associated With Prolonged PFS With Ibrutinib in WM
Response depth appeared to be predictive of PFS in WM patients treated with ibrutinib.
Quality of Life Increased Among Survivors of Aggressive Lymphoma, and Was Sustained Long-Term
Using the FACT-G questionnaire, researchers measured the quality of life for survivors of aggressive lymphomas at diagnosis and at various time points up to 9 years postdiagnosis.
Long-Term Survivors of Childhood Hodgkin Lymphoma at Increased Risk for Neurocognitive Impairment
A St Jude Children’s Research Hospital team investigated potential causes of neurocognitive impairments in survivors of childhood Hodgkin lymphoma survivors.
Risk Factors for Early Relapse of DLBCL After CAR-T Therapy
Nearly half of all relapses occurred within the first month of CAR-T infusion.
Chemotherapy-Free Combination Therapy Targeted to the Epigenome in PTCL
Peripheral T-cell lymphoma is characterized by extensive epigenetic dysregulation.
Does Type of Radiation Therapy in Hodgkin Lymphoma Treatment Affect Lung Toxicity?
Researchers examined data from patients who were treated for Hodgkin lymphoma between 2009 and 2013 who had received radiation therapy as part of their treatment.
Postmarketing Observational Study of Tisagenlecleucel for ALL or NHL Yields Promising Results
Researchers report on results with CAR-T therapy in real-world populations of patients with ALL or NHL.
Reductions in Rates of Surveillance Imaging in Patients With Diffuse Large B-Cell Lymphoma
Study results demonstrate influence of the ASH Choosing Wisely campaign regarding surveillance imaging rates in patients with DLBCL.
Mantle Cell Lymphoma: Analysis Reveals Real-World Patient Experiences With Ibrutinib
A retrospective analysis highlights the reasons for discontinuation of ibrutinib among patients with mantle cell lymphoma.
-
Loading...
-
Loading...
Next post in Lymphoma
